Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis
Jiwon Oh(St. Michael's Hospital), Peter A. Calabresi(Johns Hopkins University), Daniel S. Reich(National Institutes of Health), Peter C.M. van Zijl(Kennedy Krieger Institute), Marie Diener‐West(Johns Hopkins University), Shiv Saidha(Johns Hopkins University), Jerry L. Prince(Johns Hopkins University), Min Chen(Soochow University), Seth A. Smith(Vanderbilt University), Craig Jones(Johns Hopkins University)
Cited by 85
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
|The Lancet|2011|743
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624